Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 100,000 shares at $62.71 ($6.2M) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $6.2M DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.16 | 13,258 | $811K | 13.1% |
| 2 | $61.16 | 13,258 | $811K | 13.1% |
| 3 | $62.04 | 32,326 | $2.0M | 32.4% |
| 4 | $62.04 | 32,326 | $2.0M | 32.4% |
| 5 | $62.71 | 3,258 | $204K | 3.3% |
| 6 | $62.71 | 3,258 |
| $204K |
| 3.3% |
| 7 | $63.67 | 1,158 | $74K | 1.2% |
| 8 | $63.67 | 1,158 | $74K | 1.2% |
| Total | $61.89 avg | 100,000 | $6.2M | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |